| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
| ln Vitro |
Arterial smooth muscle cell (SMC) proliferation is time- and dose-dependently inhibited by (S)-(-)-Perillic acid (1.0-3.5 mM; 24, 48, and 72 hours) [1]. In rat arterial smooth muscle cells (SMC), (S)-(-)-Perillic acid (1.0-3.5 mM; 20 hours) dose-dependently inhibits intranuclear thymine binding [1]. In arterial smooth muscle cells, (S)-(-)-Perillic acid (2.5 mM; 24 hours) causes apoptosis and inhibits cell cycle progression in the G0/G1 phase [1]. Certain low molecular weight proteins are resistant to the incorporation of [3H]FOH and [3H]GGOH when exposed to (S)-(-)-Perillic acid (1.0-3.5 mM; 20 hours) in a dose-dependent manner [1]. In H520 cells, (S)-(-)-Perillic acid (0.5 mM; 24 hours) raises the levels of the proteins Bax, Bcl2, p21, and caspase-3 [2].
|
|---|---|
| Cell Assay |
Cell Viability Assay[2]
Cell Types: Human lung cancer A549 cell line Tested Concentrations: 0-5 mM Incubation Duration: 24 hour Experimental Results: Inhibited long-term proliferation of A549 cells with an IC50 value of 3.6 mM. |
| References |
[1]. Ferri N, et al. Effect of S(-) perillic acid on protein prenylation and arterial smooth muscle cell proliferation. Biochem Pharmacol. 2001 Dec 15;62(12):1637-45.
[2]. Yeruva L, et al. Perillyl alcohol and perillic acid induced cell cycle arrest and apoptosis in non small cell lung cancer cells. Cancer Lett. 2007 Nov 18;257(2):216-26. [3]. Khandelia H, et al. Interaction of salicylate and a terpenoid plant extract with model membranes: reconciling experiments and simulations. Biophys J. 2010 Dec 15;99(12):3887-94. |
| Additional Infomation |
4-Isopropenylcyclohexene-1-carboxylic acid has been reported in Perilla frutescens and Spodoptera litura with data available.
|
| Molecular Formula |
C10H14O2
|
|---|---|
| Molecular Weight |
165.20902
|
| Exact Mass |
166.099
|
| CAS # |
23635-14-5
|
| Related CAS # |
Perillic acid;7694-45-3
|
| PubChem CID |
2724160
|
| Appearance |
Typically exists as solid at room temperature
|
| Density |
1.068g/cm3
|
| Boiling Point |
284.9ºC at 760mmHg
|
| Melting Point |
129-131ºC(lit.)
|
| Flash Point |
134ºC
|
| Vapour Pressure |
0.000746mmHg at 25°C
|
| LogP |
2.373
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
2
|
| Rotatable Bond Count |
2
|
| Heavy Atom Count |
12
|
| Complexity |
238
|
| Defined Atom Stereocenter Count |
1
|
| SMILES |
C=C(C)[C@@H]1CC=C(CC1)C(=O)O
|
| InChi Key |
CDSMSBUVCWHORP-MRVPVSSYSA-N
|
| InChi Code |
InChI=1S/C10H14O2/c1-7(2)8-3-5-9(6-4-8)10(11)12/h5,8H,1,3-4,6H2,2H3,(H,11,12)/t8-/m1/s1
|
| Chemical Name |
(4S)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 6.0529 mL | 30.2645 mL | 60.5290 mL | |
| 5 mM | 1.2106 mL | 6.0529 mL | 12.1058 mL | |
| 10 mM | 0.6053 mL | 3.0265 mL | 6.0529 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
